Skip to content

Dr. Sofie Van den Acker

Active
Private limited companyfounded 2024active for 2 yearsLemanstraat 62, 2860 Sint-Katelijne-Waver, BelgiumKBO/BCE: BE 1014.549.823
Summary

Dr. Sofie Van den Acker has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €44,726 and a net result of €41,726. Its solvency ranks better than 69% of 20,589 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€56,614total assets 2025
Equity
€44,726
Profit
€41,726
Turnover not published (micro format)
Financial health
90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Accounts 52 days early
Why 90raises risk2 changes of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.69, cash €51,421Figures for financial year 2025 (filed 09-06-2026)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 81% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 100
equity 79.0% of total assets
Liquidity 93
short-term debt 21.0% · cash 90.8%
Profitability 100
return on assets 73.7%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,109 companies, NACE 86, micro)
Last 24 months 11-2025: 0.6% 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 2.2%▲ +1.6 percentage points vs 12-2025 02-2026: 2.2%● unchanged vs 01-2026 03-2026: 2.3%▲ +0.1 percentage points vs 02-2026 04-2026: 2.3%● unchanged vs 03-2026 05-2026: 2.3%● unchanged vs 04-2026 06-2026: 2.4%▲ +0.1 percentage points vs 05-2026highest value 07-2026: 0.3%▼ -2.1 percentage points vs 06-2026lowest value 08-2026: 0.3%● unchanged vs 07-2026lowest value 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €4,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.69, above the usual 1.5; short-term debt: 21% and cash: 90.8% of total assets), and 21% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 79% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · 2 changes of registered office in 24 months
Belgian Official Gazette
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.69, cash €51,421
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 09-06-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
52 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Registered officeRegistered-office move
  3. Registered officeRegistered-office move

Financials · financial year 2025, micro format

Equity
€44,726
Total assets
€56,614
Net result
€41,726
Working capital
€43,914

Turnover and EBIT margin not published: the micro format does not require them.

Balance-sheet composition
Assets €56,614
Fixed assets €812
Current assets €55,802
Equity and liabilities €56,614
Equity €44,726
Debt €11,888
Debt finances 21.0% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€53,838
Cash flow
€42,214
Current ratio
4.69
Debt to equity
0.27
ROE
93.3%
ROA
73.7%
Interest coverage
over 100
Debt ≤ 1 year
€11,888
Income taxes
€11,330

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.8% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.3% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 33 lines
Balance sheet Code2025
Assets
Total assets20/58€56,614
Fixed assets21/28€812
Tangible fixed assets22/27€812
Furniture and vehicles24€812
Current assets29/58€55,802
Amounts receivable within one year40/41€4,382
Trade receivables40€4,382
Cash at bank and in hand54/58€51,421
Equity and liabilities
Total equity and liabilities10/49€56,614
Equity10/15€44,726
Contributions10/11€3,000
Reserves13€41,726
Distributable reserves133€41,726
Amounts payable17/49€11,888
Amounts payable within one year42/48€11,888
Trade debts44€273
Suppliers440/4€273
Taxes, remuneration and social security45€11,330
Taxes450/3€11,330
Other amounts payable47/48€284
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€488
Other operating charges640/8€536
Gross operating margin9900€54,374
Operating profit (loss)9901€53,351
Financial charges65/66B€294
Recurring financial charges65€294
Profit (loss) for the period before taxes9903€53,057
Income taxes67/77€11,330
Profit (loss) for the period9904€41,726
Profit (loss) for the period to be appropriated9905€41,726
Appropriation of the result
Profit (loss) to be appropriated9906€41,726
Transfer to equity691/2€41,726
To other reserves6921€41,726

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€488
Other operating charges640/8€536
Gross operating margin9900€54,374
Operating profit (loss)9901€53,351
Financial charges65/66B€294
Recurring financial charges65€294
Profit (loss) for the period before taxes9903€53,057
Income taxes67/77€11,330
Profit (loss) for the period9904€41,726
Profit (loss) for the period to be appropriated9905€41,726
Line2025
Assets
Total assets20/58€56,614
Fixed assets21/28€812
Tangible fixed assets22/27€812
Furniture and vehicles24€812
Current assets29/58€55,802
Amounts receivable within one year40/41€4,382
Trade receivables40€4,382
Cash at bank and in hand54/58€51,421
Equity and liabilities
Total equity and liabilities10/49€56,614
Equity10/15€44,726
Contributions10/11€3,000
Reserves13€41,726
Distributable reserves133€41,726
Amounts payable17/49€11,888
Amounts payable within one year42/48€11,888
Trade debts44€273
Suppliers440/4€273
Taxes, remuneration and social security45€11,330
Taxes450/3€11,330
Other amounts payable47/48€284
Line2025
Profit (loss) for the period9904€41,726
+ Depreciation and write-downs630€488
Operating cash flow (approximation)€42,214

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (1)
Financial year Type Filed Reference
31-12-2025 micro format 09-06-2026 2026-00147060

Similar companies · same sector, comparable size

Of the 16,584 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,110. 4,964 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2024
VAN DEN ACKER Sofie Thomas José
Director (not named in the articles) · since 04-10-2024
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2024, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
VAN DEN ACKER Sofie Thomas José
  • Director (not named in the articles), from 04-10-2024 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 04-10-2024 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 04-10-2024 Incorporation · €3,000 · 100 shares

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

Dr. Sofie Van den Acker was incorporated on 2 October 2024 as a private limited company by one natural person, with a starting capital of €3,000.12 The registered office moved to Lier in 2025 and to Sint-Katelijne-Waver in 2025.34 Since 2024, VAN DEN ACKER Sofie Thomas José has served as director of the company.2

  1. 1KBO register
  2. 2Belgian Official Gazette, 04-10-2024
  3. 3Belgian Official Gazette, 22-01-2025
  4. 4Belgian Official Gazette, 16-12-2025

Acts, filings and financial milestones

2026
09-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
16-12
Gazette deed Registered office
Registered-office move2 facts ▸
  • General meeting, 19-11-2025
  • Registered-office move, Lemanstraat 62/A012 te 2860 Sint-Katelijne-Waver
22-01
Gazette deed Registered office
Registered-office move2 facts ▸
  • General meeting, 23-12-2024
  • Registered-office move, Begijnhofstraat 64 te 2500 Lier
2024
04-10
Gazette deed Incorporation
Appointment: VAN DEN ACKER Sofie Thomas José (director) · Founder · Founding capital8 facts ▸
  • Incorporation, 02-10-2024
  • Founder, VAN DEN ACKER Sofie Thomas José
  • Founding capital, €3,000
  • Bank account, “bijzondere bankrekening op naam van de vennootschap in oprichting” (deed in Dutch)
  • Shareholding, 100
  • Director appointment, VAN DEN ACKER Sofie Thomas José (director (not named in the articles))
  • Other provision, “registers verantwoordelijkheid, partijen zelf verantwoordelijk voor latere wijzigingen of noodzakelijke aanvullingen” (deed in Dutch)
  • Pre-incorporation commitments, “takeover, alle verbintenissen, verplichtingen en activiteiten” (deed in Dutch)
Gazette deedNBB filing
3 of 3 deeds read

Register details

Identification
Legal formPrivate limited company
Founded02-10-2024
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:1014549823
Also 9925:BE1014549823

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 23 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Sint-Katelijne-Waver · 1 establishment unit since 2024
registered office establishment The establishment unit on the map
Ground area
5,847 m²
Building footprint
390 m²
Building volume
4,566 m³
2 parcels, Flanders · tallest building 19.0 m. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Dr. Sofie Van den Acker
Berlaarsesteenweg 93, 2500 LierSpecialist medical practice
since 2024unit no. 2.367.644.987
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
12392C0045/00C000 Flanders 5,146 m² 1 · 197 m² 19.0 m · 6
12035B0142/00V005 Flanders 702 m² 1 · 193 m² 9.6 m · 3
How the parcels are linked
Good to know
Both parcels match the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“De uitoefening van de geneeskunde met de specialisatie Huisarts, in naam en voor rekening van de vennootschap, met inachtneming van de…” (deed in Dutch)
Text of the purpose (deed in Dutch)

“De uitoefening van de geneeskunde met de specialisatie Huisarts, in naam en voor rekening van de vennootschap, met inachtneming van de regels van de geneeskundige plichtenleer, betreffende het beroepsgeheim, en onder de specifieke beroepsaansprakelijkheid van de artsen-aandeelhouder(s) en de bijkomende aansprakelijkheid van de vennootschap”

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
Dr. Sofie Van den Acker
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Waterstraat 25,2860 Sint-Katelijne-Waver” (deed in Dutch)

deed of 04-10-2024

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
Each director alone
Board ruleHow the board is made up, meets and takes decisions.
“Steeds arts-aandeelhouder en regels behoorlijke beroepsuitoefening, 1” (deed in Dutch)

deed of 04-10-2024

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
First Friday of June at 18:00

deed of 04-10-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Winstverdeling, algemene vergadering” (deed in Dutch)
Liquidation distribution: “Na aanzuivering schulden,lasten,kosten of consignatie, netto actief onder alle aandeelhouders naar verhouding aantal aandelen” (deed in Dutch)
Other provision: “Interim-dividenden, artikel 5:142 WVV en 5:143 WVV” (deed in Dutch)
1 more provision in the deed, see the deed of 04-10-2024

deed of 04-10-2024